Parabolic Drugs in News

2014

Parabolic Drugs Limited has received European GMP Certifications:

• Works Site located at Derabassi for manufacture of Cephalosporin products. (Certificate No. DE_RP_01_GMP_2014_0023 dated 19.05.2014)

• Works Site located at Lalru for manufacture of Non-beta Lactams products. (Certificate No. DE_RP_01_GMP_2014_0024 dated 19.05.2014)

2014

Parabolic Drugs Limited has received European GMP Certifications:

• Works Site located at Derabassi for manufacture of Cephalosporin products. (Certificate No. DE_RP_01_GMP_2014_0023 dated 19.05.2014)

• Works Site located at Lalru for manufacture of Non-beta Lactams products. (Certificate No. DE_RP_01_GMP_2014_0024 dated 19.05.2014)

Parabolic Drugs receives Certificate of Suitability for Cefixime molecule from EU
Parabolic Drugs receives Certificate of Suitability for Cefixime molecule from EU
Parabolic Drugs 9M FY11 net profit up 65.6% to Rs. 37.30 Crores,Sales up 24.4% to Rs. 466.04 Crores(February 2nd,2011)
Parabolic Drugs Completes first phase of Expansion

2010

Parabolic Drugs Q2FY11 Net Profit up 163.65% at Rs. 14.29 crore,Sales up 16.23% at Rs. 161.43 crore (November 8th,2010)
Parabolic Drugs Q1 profit rise by 36.29% (July 20th,2010)
PDL now gets EU-GMP accreditation(July 12th,2010)
PDL gets listed on NSE and BSE (July 1st,2010)
FY results for the year ended March 31st,2010
Barwala Research and Development centre inaugurated

2009

WHO -GMP certificate for Cephalosporin facility(August 24th,2009)
ISO 14001 certification for PDL(August 6th,2010)

Quick Links
News Archives